The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase III trial of adjuvant chemotherapy following chemoradiation as primary treatment for locally advanced cervical cancer compared to chemoradiation alone: The OUTBACK TRIAL.
Linda R. Mileshkin
Research Funding - Hospira
Kailash Narayan
No relevant relationships to disclose
Kathleen N. Moore
No relevant relationships to disclose
Danny Rischin
No relevant relationships to disclose
Edward Lloyd Trimble
No relevant relationships to disclose
Martin R. Stockler
No relevant relationships to disclose
Madeleine King
No relevant relationships to disclose
Ilka Kolodziej
No relevant relationships to disclose
Julie Martyn
No relevant relationships to disclose
Michael Friedlander
No relevant relationships to disclose
Michael Quinn
No relevant relationships to disclose
Shyam K Shrivastava
No relevant relationships to disclose
William Small
No relevant relationships to disclose
Gillian Thomas
No relevant relationships to disclose
Peter S Craighead
No relevant relationships to disclose
Val Gebski
No relevant relationships to disclose